Cytotoxic drugs and other emesis-stimulating agents form free radicals that activate enterochro-maffin cells, which release serotonin. The serotonin stimulates 5-HT 3 receptors located along the ...

In a new study published in Neuron00640-8), researchers uncovered how the little-known psychedelic drug DOI ...

AMY 1 receptors are found at key sites for migraine pain, such as the trigeminal nerves. In a small study, Russo and Hay ...

A number of pharmaceutical companies are experimenting on creating the next generation of psychedelic drugs with the goal of ...

Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline.

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of ...

New, non-hallucinogenic versions of psychedelics are blurring the boundaries of the drug trip.

The drug, called Cobenfy and developed by US pharma giant Bristol Myers Squibb, works differently from existing treatments, targeting the so-called cholinergic receptors, not the dopamine receptors.

Hormone therapy (also called hormonal therapy or endocrine therapy) slows or stops the growth of hormone-sensitive tumors by blocking the body’s ability to produce hormones or by interfering with the ...

Classic psychedelics such as psilocybin and LSD enter the brain via the same receptors as serotonin, the body’s “feel good” ...

BMB-201 demonstrated dose-dependent efficacy in pain modelsBMB-201 demonstrated similar efficacy to morphine in several pain modelsNEW YORK, Oct.